Want $7,000 in Passive Income? Buy These 3 Dividend Stocks Today

Quick Read

• Amgen, Coca-Cola Europacific, and Evergy together would pay roughly $7,700 a year on $300,000, a blended 3% yield, with all three raising payouts in 2026.

• Evergy’s data center growth, including a Digital Realty letter of intent, powers the highest yield of the three at about 3%.

• Amgen’s payout consumes only about 43% of 2026 earnings guidance, giving strong coverage despite biosimilar erosion and $54 billion of debt.

• Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor)

For retirees, the hardest part of giving up a paycheck is losing its rhythm. Selling shares to cover monthly bills works fine in a rising market, but in a downturn it forces sales at the worst prices and shrinks the portfolio that has to last for decades. Dividend income works differently. The shares stay in the account, and the companies send cash on their own schedule, whatever the market is doing.

Here’s what investing $100,000 in each of these three dividend payers would generate in annual income. Spread across a $300,000 total investment, the three positions together would produce more than $7,000 a year in dividends, based on each company’s current forward dividend rate and share price as of November 10, 2026.

The group leans defensive: a biotech that is a Dow component, the largest Coca-Cola bottler by revenue, and a regulated electric utility in Kansas and Missouri. All three raised their payouts in 2026. Their yields sit below ultra-high-yield territory, so the trade-off is dividend growth and coverage in exchange for less current income per dollar. Stocks appear in countdown order, from the lowest yield to the highest.

——

Learn 7 Ways To Generate Income With A $1,000,000+ Portfolio

If you’ve saved over $1,000,000, this guide is for you. The last thing you want in retirement is to run out of money, you want your money to generate lasting income while you enjoy your life.

Now you can learn the strategies wealthy retirees use to fund their retirement with The Definitive Guide to Retirement Income from Fisher Investments. Download the guide today! (sponsor)

——

3. Amgen: A Dow Biotech That Keeps Raising Its Payout

• Forward Yield: 2.18%

• Shares for $100,000: 216.34

• Annual Passive Income: ~$2,180.69

Amgen (NASDAQ:AMGN) discovers, develops, manufactures, and sells medicines across general medicine, rare disease, inflammation, and oncology. It is building an obesity position led by MariTide, its monthly GLP-1/GIPR candidate now in a broad Phase 3 program. Third-quarter revenue came in at $10.365 billion, up 8.4% year over year and ahead of the $10.07 billion consensus, while non-GAAP EPS of $6.45 beat the $5.78 estimate. Repatha grew 37% to $1.085 billion, and Uplizna rose 191%. CEO Robert A. Bradway said, “Amgen delivered another strong quarter as our strategy for long-term growth continued to produce results across the enterprise.”